E&C Pegs FDA, Reform Law Grandfathering, SGR Reform As Top Fall Priorities

E&C Pegs FDA, Reform Law Grandfathering, SGR Reform As Top Fall Priorities - InsideHealthPolicy.com: The House Energy and Commerce Committee is prioritizing changes to FDA's medical device and drug regulatory approaches as part of the fall 2011 agenda ahead of user fee reauthorizations next year, with the panel also setting its sites on both tackling healthcare reform's grandfathering regulations and options to alter the Medicare physician payment formula, the Republican leadership of the committee said Tuesday (Sept. 6) as Congress returned from the summer recess.